首页> 外文期刊>Stem cells international >Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering
【24h】

Mesenchymal Stromal/Stem Cells in Regenerative Medicine and Tissue Engineering

机译:再生医学和组织工程中的间充质基质/干细胞

获取原文
获取原文并翻译 | 示例
       

摘要

As a result of over five decades of investigation, mesenchymal stromal/stem cells (MSCs) have emerged as a versatile and frequently utilized cell source in the fields of regenerative medicine and tissue engineering. In this review, we summarize the history of MSC research from the initial discovery of their multipotency to the more recent recognition of their perivascular identity in vivo and their extraordinary capacity for immunomodulation and angiogenic signaling. As well, we discuss long-standing questions regarding their developmental origins and their capacity for differentiation toward a range of cell lineages. We also highlight important considerations and potential risks involved with their isolation, ex vivo expansion, and clinical use. Overall, this review aims to serve as an overview of the breadth of research that has demonstrated the utility of MSCs in a wide range of clinical contexts and continues to unravel the mechanisms by which these cells exert their therapeutic effects.
机译:由于超过五十年的调查,间充质基质/干细胞(MSCs)被出现为再生医学和组织工程领域的通用和经常使用的细胞来源。在这篇综述中,我们总结了MSC研究的历史,从初步发现了他们的多能量,以更新识别其体内血管内同一性及其非凡的免疫调节和血管生成信号传导能力。同样,我们讨论了有关其发展起源的长期问题及其对一系列细胞谱系的差异化的能力。我们还突出了涉及其孤立,exvivo扩展和临床用途所涉及的重要考虑因素和潜在风险。总体而言,本综述旨在担任研究的广度概述,这已经证明了MSCs在广泛的临床环境中的效用,并继续解开这些细胞施加治疗效果的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号